Navigation Links
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results

er similar expressions are forward-looking statements that involve a number of risks and uncertainties. By their nature, forward-looking statements involve numerous factors, assumptions and estimates, some but not all of the factors that could cause actual results to differ materially from those projected in our forward-looking statements include among others: risks associated with the completion of clinical trials and obtaining regulatory approval to market our products, market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain and develop partnership opportunities; and other risk factors identified from time to time in the Company's regulatory filings. For a further description of the principal risks affecting the Company, see our regulatory filings. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements.

Contact:
Inflazyme Pharmaceuticals Ltd.
Julie Rezler, Sr. Director, Corporate Development
Tel: 1.800.315.3660/604.279.8511
Fax: 604.279.8711
E-mail: ir@inflazyme.com
Website: www.inflazyme.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/7/2015)...  New study findings reveal that more complications occur ... for prostate cancer . Researchers from ... at the Canadian Urological Association annual meeting in ... that prostate cancer patients who undergo radiation therapy have ... procedures due to treatment complications. They analyzed over 60,000 ...
(Date:7/6/2015)... 6, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... cancellation of its previously announced underwritten public offering of ... $0.87 per unit. Canaccord Genuity was ... was acting as co-manager for the offering. ...
(Date:7/6/2015)... 2015  Nitin Tandon, M.D., UTHealth neurosurgeon and ... Hermann Mischer Neuroscience Institute at the Texas ... technology into the skull of a 36-year-old epilepsy ... – the first time this procedure has been ... is a neurological condition that affects nearly three ...
Breaking Medicine Technology:New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 2New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 4EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4
... WIRE via COMTEX News Network),-- Endo Pharmaceuticals ... Holdings Inc. (NASDAQ: ENDP), has presented results,from ... evaluating Frova (frovatriptan succinate) 2.5 mg,tablets as ... menstrual migraine (MM). The data demonstrated,that FROVA ...
... SALT LAKE CITY, UT, June 11, 2007 ... Genetics, Inc. (NASDAQ: MYGN) (<a target=,"_blank" href="http://www.myriad.com/">www.myriad.com ... comparison of a,"Staggered Start" and a "Randomized ... Staggered Start" clinical trial,design at the Alzheimer's ...
Cached Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5
(Date:7/7/2015)... , ... July 07, 2015 , ... Parents and guardians ... by A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse ... Drug Use and HIV Research has shown a significant increase in the “club drug” ...
(Date:7/7/2015)... ... , ... FSAstore.com today announced the launch of its sister site ... simple to use, spend and manage HSA funds with innovative tools including an ... to a report by Devenir , approximately 13.8 million Americans have an HSA, ...
(Date:7/7/2015)... Antonio, TX (PRWEB) , ... July 07, 2015 , ... ... has once again teamed up with Soldiers’ Angels and announced a new charity campaign ... is the motivation and mission of Soldiers’ Angels, which was created especially to care ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... firm, today announced that TimberNook ( http://www.timbernook.com/ ) has selected the ... strategy, and marketing launch package for new camp providers. TimberNook is a ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... into potentially explosive environments with the introduction of the Nightstick XPP-5422GM , ... feature dual magnets, one at its base and one on its clip. The ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 3
... in vitro fertilization technique that can avoid multiple births ... according to researchers at the Stanford University School of ... retrospective study became pregnant after undergoing the procedure, called ... into the womb. , Nearly 60 percent of IVF ...
... concerned than ever,about the products they use and their impact ... an every day routine, it can encompass an,eco-conscious way of ... line of personal care products, which are both healthy for ... than just personal,care benefits; it reinforces a commitment to preserving ...
... Pharmacy and Midwest,Veterinary Supply, Inc. (Burnsville MN) ... will represent Wedgewood,s compounding pharmacy,services to 9,000 ... is,effective October 1. This is the first ... service. Through the Midwest relationship, Wedgewood,s ...
... PHILADELPHIA, Oct. 1 The national law ... announced that it is forming a,Professional Liability practice ... Hoffman including name partner Peter Hoffman. The group ... Eckert Seamans, Philadelphia,and Harrisburg offices and create a ...
... Inc., a supplier,of affordable medical imaging systems to healthcare ... vice president of Sales,and Business Development for the company. ... Radlink to the,next level," says Tom Hacking, chairman and ... look forward to the many contributions he,will make." ...
... Michael Educational Institute LLC Introduces New Educational ... Resource at IDSA Annual ... Institute LLC will introduce a new continuing education,resource as part ... the,Infectious Diseases Society of America (IDSA), October 4-7, in San ...
Cached Medicine News:Health News:IVF technique enables pregnancy without multiple births, Stanford researchers find 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 3Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 3Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 2Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 3Health News:National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks 2
SofLens Multi-Focal with unique Natra-Sight Optics designed to provide broad transition for near, intermediate and far vision, SofLens Multi-Focal lenses offer crisp, clear vision at all distances....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
... uses reflection mirrors to measure the ... after tumor removal or thyroid decompression. ... Naugle is easy to handle- with ... and plastic mounts that are placed ...
Medicine Products: